SMARCA1 and neoplasm: By interacting with the Switch-Sucrose Non-Fermentable (SWI/SNF) complex for the purpose of chromatin remodeling, SChLAP1 is able to reverse the effects of SWI/SNF, which are known to decrease tumor growth (Prensner et al., 2013).